A.I. BASED MEDICINE
... following further mutations in the SARS-CoV-2 virus – Dr. Hess reserves judgment on vaccination.
The eyes of the entire scientific world are currently fixed on two countries: on the on...
Doctor Hess introduces infection and vaccination log for Premium Clients.
This last year has gone by surprisingly fast for us, and it seems like only yesterday that we were putting our tea...
Right from the start, SARS CoV-2 has measured up to the two main criteria of a model pandemic virus: it spreads easily and kills only a small percentage of those infected. However, new mutant fo...
We have been monitoring tocilizumab for some time now and have already reported on its potential in previous Keynotes. We are of the opinion that it could, under certain circumstances, be used i...
... of vaccination are minimal to zero.
This internal study involved Dr Robert Hess Premium clients who have subscribed to our Covid-19 Immunization Program since April 2020, who have a Co...
... vaccines and optimization of the immune system is becoming an increasingly uphill challenge.
Dr Robert Hess SARS-CoV-2 Task Force was set up in January 2020 with the aim of providing h...
The alpha version of this monitoring program will be applied immediately to all retests for Premium clients at no extra charge.
New strategy emphasis for Dr. Hess clients group in 2022.
Dr Robert Hess considers that the likelihood of a major vaccine campaign bringing the pandemic to an end this summer is diminishin...
We are not surprised by the latest developments surrounding the current crop of vaccines and the problems that have arisen, especially with regard to AstraZeneca. Since April 2020, we have repea...
Since posting our previous podcast in which we detailed our concerns about vector-based vaccines – more specifically AstraZeneca – as the possible cause of thrombosis, more material has come to ...